Longitude Capital is a venture capital firm that specializes in investments in biotechnology, medical technology, and health solutions. Founded in 2006 and based in Menlo Park, California, with an additional office in Boston, Massachusetts, the firm has raised over $2 billion across six funds and manages approximately $1.7 billion in assets. The firm focuses on improving clinical outcomes and enhancing patient quality of life while reducing healthcare costs. Longitude Capital invests in both privately held and publicly traded companies, utilizing various investment structures. Beyond providing capital, the firm offers strategic guidance and mentorship to its portfolio companies, assisting them in achieving key objectives and building strong teams. With a team that has over 200 years of combined experience in life sciences, Longitude Capital has made over 90 new investments and 150 follow-on investments, leveraging a broad industry network and proprietary research capabilities to identify emerging opportunities in healthcare.
我們正在追蹤 Longitude Capital 的市場擴張
Longitude Capital 的國際擴張與競爭對手的比較
Longitude Capital你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Longitude Capital你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
海思科醫藥將HSK39004全球權利授權給AirNexis，交易總額高達10.63億美元，標誌著中國呼吸領域創新藥國際化的重要突破。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Longitude Capital 業務、市場及增長訊號的快速解答。
